This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (195)
Death (21)
Life Threatening Events (2)
Disability (20)
Reports by Reaction Type
Nephrogenic Systemic Fibrosis (177),
Pain (132),
Mobility Decreased (87),
Anxiety (81),
Skin Induration (80),
Emotional Distress (79),
Skin Tightness (78),
Oedema Peripheral (74),
Joint Range of Motion Decreased (64),
General Physical Health Deterioration (62),
Injury (61),
Skin Hypertrophy (61)
Below are a few examples of reports where side effects / adverse reactions may be related to Optimark (Gadoversetamide). For a complete list or a specific selection of reports, please use the links above.
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male, weighing 91.0 kg (200.2 pounds)
Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Indication: Osteomyelitis
Gadolinium IN Unspecified Drug
Indication: Diabetic Foot
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-05
End date: 2002-11-05
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-01-14
End date: 2005-01-14
Magnevist
Dosage: 15 ml, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Magnevist
Dosage: unk unk, once
Start date: 2005-01-25
End date: 2005-01-25
Magnevist
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-11-15
End date: 2002-11-15
Magnevist
Dosage: 19 ml, once
Start date: 2004-07-16
End date: 2004-07-16
Multihance
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Prohance
Dosage: unk unk, once
Indication: Angiogram
Start date: 2002-10-16
End date: 2002-10-16
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix
Possible Optimark side effects in 49 year old male
Reported by a lawyer from United States on 2012-08-02
Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Start date: 2004-05-19
End date: 2004-05-19
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-05-19
End date: 2006-05-19
Magnevist
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-10-13
End date: 2006-10-13
Magnevist
Dosage: 20 ml, unk
Start date: 2006-10-17
End date: 2006-10-17
Multihance
Indication: Product Used FOR Unknown Indication
Omniscan
Omniscan
Dosage: 50 ml omniscan+co2
Indication: Fistulogram
Start date: 2006-08-04
End date: 2006-08-04
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-05
End date: 2006-08-05
Optimark
Indication: Product Used FOR Unknown Indication
Prohance
Indication: Computerised Tomogram Head
Start date: 2004-05-19
End date: 2004-05-19
Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine
Possible Optimark side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: female
Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 56 year old female
Reactions: Pruritus, Abasia, Pain, Joint Contracture, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Rash, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Mobility Decreased, Scar
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-05-21
End date: 2004-05-21
Magnevist
Indication: Renal Mass
Optimark
Indication: Muscular Weakness
Optimark
Indication: Disorientation
Optimark
Indication: Headache
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Other drugs received by patient: Lantus; Sensipar; Slow Release Iron; Prograf; Phoslo; Renvela; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone; Procrit; Atenolol
Possible Optimark side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Pruritus, Dysphagia, Urticaria
Drug(s) suspected as cause:
Hexabrix
Dosage: unk unk, single
Indication: Arthrogram
Start date: 2011-10-25
End date: 2011-10-25
Optimark
Dosage: 5 ml, single
Indication: Arthrogram
Start date: 2011-10-25
End date: 2011-10-25
Sodium Chloride
Dosage: 12 ml, single
Indication: Arthrogram
Start date: 2011-10-25
End date: 2011-10-25
Possible Optimark side effects in male
Reported by a physician from United States on 2012-07-30
Patient: male, weighing 110.7 kg (243.5 pounds)
Reactions: Hyperbilirubinaemia, Chest Pain, Pleural Effusion, Depression, Contrast Media Allergy, Acute Myocardial Infarction, Cardiac Failure Congestive, Vomiting, Cellulitis, Nausea, Coronary Artery Disease, Hyponatraemia, Bacterial Disease Carrier, Ventricular Tachycardia, Hypoalbuminaemia, Gallbladder Polyp, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Optimark
Dosage: 15 ml, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2007-01-17
End date: 2007-01-17
Optimark
Other drugs received by patient: Aciphex; Ibuprofen; Multiple Vitamins; Crestor; Levitra; Lisinopril
Possible Optimark side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-27
Patient: female
Reactions: Pruritus, Pain, Muscle Contracture, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Skin Ulcer, Arthralgia, Fibrosis, Injury, Disability
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Possible Optimark side effects in female
Reported by a lawyer from United States on 2012-07-26
Patient: female, weighing 118.8 kg (261.4 pounds)
Reactions: Lymphadenopathy, Septic Encephalopathy, Tachycardia, Decubitus Ulcer, Upper Respiratory Tract Infection, Iron Deficiency Anaemia, Dermatitis, Graft Thrombosis, Oedema Peripheral, Pulmonary Oedema, Hyperphosphataemia, Hypertensive Heart Disease, Hypotension, Nephrogenic Systemic Fibrosis, Gene Mutation Identification Test Positive, Electrocardiogram QT Prolonged, Wheezing, Drug Interaction, Fall, Blood Bilirubin Decreased, Hyperparathyroidism, Erosive Oesophagitis, Graft Infection, Fluid Overload, Dyspnoea, Haemorrhoids, Syncope, Pericarditis, Sepsis, Sinus Disorder, Hypothyroidism, Asthma, Bronchopneumonia, Pleuritic Pain, Coagulopathy, Pulmonary Embolism, Cardiac Failure Acute, Duodenitis, Colon Adenoma, Nodule, Electrocardiogram T Wave Abnormal, Carpal Tunnel Syndrome, Abscess Limb, Pain in Extremity, Breast Calcifications, Respiratory Distress, Insomnia, Dyslipidaemia, Diverticulum Intestinal Haemorrhagic, Pain, Gastritis, Hypokalaemia, Myalgia, Neuropathy Peripheral, Pericardial RUB, Azotaemia, Gastrooesophageal Reflux Disease, Jugular Vein Thrombosis, Systemic Sclerosis, Tracheobronchitis, Migraine, Haemoptysis, Atrial Fibrillation, Renal Failure Chronic, Pneumonia Bacterial, Diarrhoea, Gastroenteritis, Protein C Deficiency, Hypertension, Superior Vena Cava Syndrome, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gadolinium
Dosage: unk, single
Indication: Angiogram
Start date: 2004-02-06
End date: 2004-02-06
Optimark
Dosage: 15 ml, single
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-08-31
End date: 2005-08-31
Other drugs received by patient: Nephro-Vite / 01801401 /; Guaifenesin DM; Diovan; Renagel; Lorazepam; Accupril; Azithromycin; Tylenol with Codein #3; Propoxyphene HCL; Zosyn; Albuterol; Atenolol; Epogen; Calcitriol; Lasix; Atrovent; Hydralazine HCL
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: 56 year old female
Reactions: Pruritus, Abasia, Joint Contracture, Pain, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Fibrosis, Injury, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, DRY Skin, Nephrogenic Systemic Fibrosis, Rash, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Scar, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Magnevist
Indication: Renal Mass
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Muscular Weakness
Optimark
Indication: Headache
Optimark
Indication: Disorientation
Other drugs received by patient: Sensipar; Renvela; Prograf; Prednisone; Procrit; Phoslo; Lantus; Slow Release Iron; Atenolol; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]
Possible Optimark side effects in 79 year old female
Reported by a physician from United States on 2012-07-20
Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)
Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia
Adverse event resulted in: death
Drug(s) suspected as cause:
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Gadolinium Zeolite
Start date: 2005-08-16
End date: 2005-08-16
Gadolinium Zeolite
Start date: 2001-05-03
End date: 2001-05-03
Gadolinium Zeolite
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2001-03-05
End date: 2001-03-05
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-04-25
End date: 2001-04-25
Magnevist
Indication: Angiogram
Start date: 2001-05-03
End date: 2001-05-03
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Multihance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Multihance
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: dose reported as eight 20ml vials (160ml)
Start date: 2005-09-20
End date: 2005-09-20
Omniscan
Dosage: route reported as ^first via distal port and then via the proximal port^
Indication: Angiogram
Start date: 2003-12-04
End date: 2003-12-04
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-05-23
End date: 2003-05-23
Omniscan
Dosage: dose reported as ^11^ 20ml vials
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-09-01
End date: 2005-09-01
Optimark
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2005-08-16
End date: 2005-08-16
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Prohance
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar
Possible Optimark side effects in 44 year old female
Reported by a physician from United States on 2012-07-18
Patient: 44 year old female, weighing 130.0 kg (286.0 pounds)
Reactions: Pain, Fear, Scleroderma, Hand Deformity, Skin Discolouration, Oedema, Musculoskeletal Stiffness, Injury, Systemic Sclerosis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Sclerodactylia, Anxiety, Emotional Distress, Arthralgia, Gait Disturbance, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Optimark
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-02-06
Optimark
Dosage: unk
Indication: Angiogram
Start date: 2005-05-31
Optimark
Dosage: unk
Start date: 2005-08-31
Other drugs received by patient: Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Coumadin; Accupril; Atenolol; Epogen; Renagel; Calcitriol; Diovan; Norvasc
Possible Optimark side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12
Patient: 58 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Deformity, Skin Plaque, Skin Tightness, Gait Disturbance, Skin Fibrosis, Mobility Decreased, Scar
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Sensipar; Ativan; Lisinopril; Loperamide; Folic Acid; Tylenol W / Codeine NO. 3; Magnesium Oxide; Plavix; Epogen; Calcijex; Zosyn; Ambien; Vitamin K1; Clonidine; Albumin (Human); Roxanol; Velcade; Adenosine; Aspirin; Dexamethasone; Acetaminophen; Compazine; Dilaudid; Foltx; Diflucan; Vancomycin; Potassium Chloride; Bactrim DS; Ciprofloxacin HCL; Hydroxyzine; Acyclovir; Mucomyst; Biaxin; Metoprolol Tartrate; Atarax; Cyclophosphamide; Norco; Neurontin; Digoxin; Ativan; Prevacid; Dexamethasone; Zoloft; Vitamin K1; Ocean; Senokot; Neupogen; Bicitra; Allopurinol; Pravachol; Levaquin; Phoslo; Gentamicin; Nephrocaps; Adriamycin PFS; Simethicone; Zemplar; Plendil; Midodrine Hydrochloride; Renaphro; Renagel; Ativan; Oxacillin; Etoposide; Reglan; Reglan; Compazine; Warfarin Sodium; Prograf
Possible Optimark side effects in 51 year old female
Reported by a lawyer from United States on 2012-07-09
Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)
Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-01-11
End date: 2001-01-11
Magnevist
Indication: Arteriovenous Fistula Operation
Start date: 2006-11-28
End date: 2006-11-28
Magnevist
Dosage: unk, once
Indication: Venous Pressure Increased
Start date: 2004-12-09
End date: 2004-12-09
Magnevist
Indication: Dialysis Efficacy Test
Start date: 2006-09-26
End date: 2006-09-26
Magnevist
Indication: Dialysis Device Insertion
Multihance
Indication: Fistulogram
Multihance
Indication: Venogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Fistulogram
Omniscan
Indication: Venogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Venogram
Optimark
Indication: Fistulogram
Prohance
Indication: Venogram
Prohance
Indication: Fistulogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl
Possible Optimark side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-06
Patient: female
Reactions: Pain, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Fibrosis, Injury, Disability
Drug(s) suspected as cause:
Magnevist
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: 54 year old male
Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-11-29
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-12-12
End date: 2000-12-12
Magnevist
Omniscan
Optimark
Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec
Possible Optimark side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-28
Patient: male, weighing 83.0 kg (182.6 pounds)
Reactions: Pruritus, Pain, Quality of Life Decreased, Muscular Weakness, Orthostatic Hypotension, DRY Skin, Stasis Dermatitis, Nephrogenic Systemic Fibrosis, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Magnevist
Indication: Angiogram
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Magnevist
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1998-05-18
End date: 1998-05-18
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Pepcid; Meclizine; Prednisone TAB; Diovan; Plavix; Nexium; Flomax; Warfarin Sodium; Covera-HS; Norvasc; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Coumadin; Epogen; Monopril; Cytoxan; Accupril; Aspirin; Sensipar; Novolin [insulin]; Hydralazine Hydrochloride; Ancef; Acetaminophen; Kayexalate; Humulin [insulin Human Injection, Isophane]; Norvasc; Phoslo; Catapres; Prevacid; Renvela; Lasix; Amiodarone Hydrochloride; Ascorbic Acid; Fish OIL; Sodium Polystyrene Sulfonate; Procrit; Zaroxolyn; Diuril; Darvocet; Neurontin; Renagel; Clonidine; Levothyroxine; Demadex; Potassium Chloride; Verapamil; Percocet; Lopressor; Lipitor
Possible Optimark side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Deformity, Skin Plaque, Skin Tightness, Scar, Skin Fibrosis, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Indication: Angiogram
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Bicitra; Foltx; Plavix; Dexamethasone; Acetaminophen; Adriamycin PFS; Compazine; Dilaudid; Pravachol; Phoslo; Vitamin K1; Etoposide; Reglan; Hydroxyzine; Plendil; Neupogen; Acyclovir; Digoxin; Mucomyst; Renagel; Calcijex; Levaquin; Simethicone; Renaphro; Sensipar; Biaxin; Dexamethasone; Zosyn; Ciprofloxacin; Ocean; Loperamide; Senokot; Clonidine; Albumin (Human); Diflucan; Magnesium Oxide; Potassium Chloride; Gentamicin; Ambien; Compazine; Velcade; Adenosine; Ativan; Lisinopril; Epogen; Oxacillin; Reglan; Zemplar; Roxanol; Allopurinol; Tylenol W / Codeine NO. 3; Ativan; Zoloft; Nephrocaps; Vitamin K1; Cyclophosphamide; Norco; Midodrine Hydrochloride; Warfarin Sodium; Prograf; Folic Acid; Ativan; Aspirin; Prevacid; Metoprolol Tartrate; Vancomycin; Bactrim DS; Atarax; Neurontin
Possible Optimark side effects in 58 year old female
Reported by a consumer/non-health professional from United States on 2012-06-22
Patient: 58 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Scab, Skin Burning Sensation, Skin Hyperpigmentation, Joint Stiffness, Anhedonia, Oedema Peripheral, Skin Swelling, Peau D'orange, Pain in Extremity, Muscular Weakness, Skin Disorder, Skin Induration, Livedo Reticularis, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Rash Macular, Anxiety, Mobility Decreased, Scar, Skin Fibrosis
Drug(s) suspected as cause:
Magnevist
Dosage: 20 ml, unk
Indication: Imaging Procedure
Start date: 2003-12-20
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-05-26
End date: 2005-05-26
Magnevist
Dosage: 15 ml, unk
Indication: Angiogram
Start date: 2006-05-30
Multihance
Indication: Imaging Procedure
Omniscan
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Prohance
Indication: Imaging Procedure
Other drugs received by patient: Klonopin; Calcitriol; Norvasc; Zemplar; Epogen; Folbee; Immunosuppressive Agents; Sensipar; Plavix; Colchicine; Renagel; Robaxin; Synthroid; Levothyroxine Sodium; Phoslo; Immunosuppressive Agents; Corticosteroids; Hormones and Related Agents; Coumadin; Gabapentin; Antithrombotic Agents; Steroid Antibacterials; Midodrine Hydrochloride; Aspirin; Neurontin; Iron Supplement; Nephrocaps
Possible Optimark side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20
Patient: 59 year old male
Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Post Thrombotic Syndrome, Skin Discolouration, Induration, Oedema Peripheral, Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram Peripheral
Start date: 2003-10-24
End date: 2003-10-24
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2003-07-17
End date: 2003-07-17
Magnevist
Omniscan
Optimark
Other drugs received by patient: Verapamil; Lasix; Coumadin; Clonidine; Epogen; Minoxidil; Albuterol; Calcitriol; Lanoxin; Renagel; Sensipar; Glyburide; Flovent; Insulin; Iron Sulfatethiamin Compound TAB
Possible Optimark side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-18
Patient: 59 year old male
Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Post Thrombotic Syndrome, Oedema Peripheral, Induration, Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram Peripheral
Start date: 2003-10-24
End date: 2003-10-24
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2003-07-17
End date: 2003-07-17
Magnevist
Omniscan
Optimark
Other drugs received by patient: Albuterol; Minoxidil; Renagel; Insulin; Calcitriol; Lanoxin; Verapamil; Lasix; Epogen; Sensipar; Flovent; Coumadin; Glyburide; Clonidine; Iron Sulfatethiamin Compound TAB
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-18
Patient: male
Reactions: Nephrogenic Systemic Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Optimark
Possible Optimark side effects in female
Reported by a physician from United States on 2012-06-18
Patient: female
Reactions: Abdominal Pain, Pulmonary Hypertension, Pruritus, Contusion, Nocturia, Hyperhidrosis, Cardiomegaly, Pericardial Effusion, Off Label Use, Biliary Dilatation, Melanocytic Naevus, Open Wound, Nephrogenic Systemic Fibrosis, Joint Swelling, Impaired Gastric Emptying, Mobility Decreased, Renal Transplant, Wheezing, Chills, Morganella Infection, Polyuria, Constipation, Splenic Infarction, Gastritis, Myalgia, Weight Increased, Fatigue, Hepatomegaly, Skin Ulcer, Dizziness, Pleural Effusion, Musculoskeletal Stiffness, Cholecystitis, Splenomegaly, Decreased Appetite, Device Related Sepsis, Nausea, Muscular Weakness, Rash, Hypercoagulation, Cerebrovascular Accident, Ascites, Arthralgia, Bradycardia, Renal Tubular Necrosis, Proteus Infection
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Optimark
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-02
End date: 2006-08-02
Optimark
Dosage: 20 ml, single
Indication: Angiogram
Start date: 2006-08-05
End date: 2006-08-05
Other drugs received by patient: Metoclopramide; Procardia XL; Epogen; Lisinopril; Renagel; Colace; Micardis; Terazosin HCL; Calcium Acetate; Novolog; Levaquin; Metoprolol Succinate Extended Release; Flagyl
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 54 year old male
Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2000-12-12
End date: 2000-12-12
Magnevist
Omniscan
Optimark
Possible Optimark side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 59 year old male
Reactions: Coronary Artery Disease, Atrial Fibrillation, Muscular Weakness, Venous Insufficiency, Nephrogenic Systemic Fibrosis, Hemiparesis, Cardiomyopathy, Cardiogenic Shock, Cerebrovascular Accident, Post Thrombotic Syndrome, Skin Discolouration, Induration, Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram Peripheral
Start date: 2003-10-24
End date: 2003-10-24
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Angiogram
Start date: 2003-07-17
End date: 2003-07-17
Magnevist
Omniscan
Optimark
Other drugs received by patient: Verapamil; Minoxidil; Insulin; Sensipar; Albuterol; Calcitriol; Epogen; Lanoxin; Renagel; Coumadin; Iron Sulfatethiamin Compound TAB; Glyburide; Clonidine; Flovent; Lasix
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-11
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Nephrogenic Systemic Fibrosis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Contrast Media
Indication: Decubitus Ulcer
Start date: 2005-04-14
End date: 2005-04-14
Contrast Media
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Magnevist
Multihance
Indication: Diagnostic Procedure
Omniscan
Indication: Liver Disorder
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Neck Pain
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Osteomyelitis
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-15
End date: 2004-10-15
Optimark
Prohance
Indication: Renal Mass
Start date: 2003-07-03
End date: 2003-07-03
Prohance
Indication: Renal Scan
Start date: 2003-07-03
End date: 2003-07-03
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Other drugs received by patient: Plavix; Iron; Clonidine; Calcitriol; Proamatine; Epogen; Renvela; Cozaar; Calcium Carbonate; Metoprolol Tartrate; Sensipar; Rena-Vite; Phoslo; Hectorol; Renagel; Amlodipine; Fosrenol; Lisinopril; Foltx
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-04-14
End date: 2005-04-14
Magnevist
Multihance
Omniscan
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-15
End date: 2004-10-15
Omniscan
Dosage: 30 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-13
End date: 2004-07-13
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Optimark
Prohance
Dosage: 17 ml, once
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-07-03
End date: 2003-07-03
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx
Possible Optimark side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)
Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Musculoskeletal Stiffness, Fibrosis, Cellulitis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Rash, Deformity, Skin Tightness, Skin Plaque, Scar, Mobility Decreased, Skin Fibrosis
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-20
End date: 2005-05-20
Gadolinium IN Unspecified Drug
Indication: Angiogram
Gadolinium IN Unspecified Drug
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-31
End date: 2004-10-31
Magnevist
Dosage: 20 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-09-27
End date: 2003-09-27
Magnevist
Dosage: unk
Indication: Computerised Tomogram Abdomen
Start date: 2004-10-03
End date: 2004-10-03
Magnevist
Dosage: unk
Start date: 2004-11-10
End date: 2004-11-10
Magnevist
Dosage: unk
Start date: 2004-12-13
End date: 2004-12-13
Magnevist
Dosage: unk
Start date: 2004-07-01
End date: 2004-07-01
Magnevist
Dosage: unk
Indication: Imaging Procedure
Start date: 2004-10-29
End date: 2004-10-29
Magnevist
Dosage: unk
Indication: Angiogram
Start date: 2005-02-17
End date: 2005-02-17
Magnevist
Dosage: 20 ml, once
Start date: 2005-05-19
End date: 2005-05-19
Magnevist
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-01-15
End date: 2004-01-15
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Ativan; Biaxin; Acetaminophen; Ciprofloxacin; Nephrocaps; Cyclophosphamide; Etoposide; Neupogen; Neurontin; Warfarin Sodium; Phoslo; Loperamide; Hydroxyzine; Acyclovir; Zoloft; Vitamin K1; Dilaudid; Albumin (Human); Midodrine Hydrochloride; Foltx; Digoxin; Pravachol; Dexamethasone; Epogen; Gentamicin; Ambien; Clonidine; Bicitra; Mucomyst; Magnesium Oxide; Calcijex; Zosyn; Vitamin K1; Adriamycin PFS; Ocean; Reglan; Compazine; Roxanol; Velcade; Allopurinol; Adenosine; Sensipar; Diflucan; Renagel; Ativan; Ativan; Prevacid; Bactrim DS; Simethicone; Norco; Prograf; Tylenol W / Codeine NO. 3; Dexamethasone; Reglan; Plendil; Renaphro; Folic Acid; Aspirin; Plavix; Lisinopril; Metoprolol Tartrate; Levaquin; Vancomycin; Potassium Chloride; Atarax; Oxacillin; Zemplar; Compazine; Senokot
Possible Optimark side effects in female
Reported by a physician from United States on 2012-06-01
Patient: female
Reactions: Atelectasis, Lymphadenopathy, Hyperkalaemia, Fall, Gastritis, Dyspnoea Exertional, Fatigue, Basal Cell Carcinoma, Hyperparathyroidism, Colon Adenoma, Graft Thrombosis, Pneumoperitoneum, Bone Giant Cell Tumour Benign, Melanocytic Naevus, Splenomegaly, Localised Infection, Pneumonia, Dyspnoea, Adnexa Uteri Mass, Excoriation, Haemorrhoids, Muscular Weakness, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Osteopenia, Paraesthesia, Skin Plaque, Cholelithiasis, Skin Papilloma, Sleep Disorder, Diarrhoea, Aortic Dilatation, Gait Disturbance, Asthenia, Venous Injury
Drug(s) suspected as cause:
Optimark
Dosage: unk, single
Start date: 2002-06-27
End date: 2002-06-27
Optimark
Dosage: unk, single
Start date: 2003-04-17
End date: 2003-04-17
Optimark
Dosage: unk, single
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2002-05-16
End date: 2002-05-16
Other drugs received by patient: Zerit; Prevacid; Viracept; Reglan; Epogen; Lamivudine; Dapsone; Klonopin; Phoslo
Possible Optimark side effects in female
Reported by a lawyer from United States on 2012-06-01
Patient: female
Reactions: Nephrogenic Systemic Fibrosis
Drug(s) suspected as cause:
Optimark
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01
Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)
Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Skin Hyperpigmentation, Scleroderma, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Rash Papular, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Sclerodactylia, Skin Tightness, Macule, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-13
End date: 1999-10-13
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2007-03-21
End date: 2007-03-21
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-11-18
End date: 2008-11-18
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-28
End date: 1999-10-28
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-01-14
End date: 2006-01-14
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1999-09-20
End date: 1999-09-20
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Fistulogram
Start date: 1999-10-08
End date: 1999-10-08
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-02-04
End date: 2006-02-04
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-03-19
End date: 2008-03-19
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-09-27
End date: 1999-09-27
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-08-13
End date: 2008-08-13
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Hydrocodone Bitartrate + Acetaminophen; Phoslo; Calcium Acetate; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Renvela
|